BAH vs. VRSK Stock Comparison: Earnings Recap, Results, and Forward Guidance
Key Takeaways
-
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations.
-
Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
-
VRSK guided FY2026 revenue to $3.19–$3.24 billion and adjusted EPS to $7.45–$7.75, highlighting AI-driven analytics and shareholder returns.
-
BAH narrowed FY2026 revenue guidance to $11.3–$11.4 billion and raised adjusted EPS to $5.95–$6.15, as cost discipline offsets government shutdown impacts.
-
Valuations diverge sharply: VRSK trades near 28x trailing earnings on $3.07 billion TTM revenue, while BAH trades near 12x P/E on $11.41 billion TTM revenue.
Why This Comparison Matters
Recent earnings from Booz Allen Hamilton and Verisk Analytics underscore the differing dynamics within professional and information services. BAH, heavily exposed to U.S. government spending, faces funding delays but benefits from demand for AI, cybersecurity, and national security solutions. VRSK, by contrast, operates a largely subscription-based analytics model serving insurers, offering steadier growth and higher margins.
Comparing the two highlights a classic trade-off for investors: BAH’s scale and value pricing versus VRSK’s predictability, profitability, and recurring revenue profile.
Verisk Analytics: Consistent Growth and Cash Returns
Verisk reported Q4 2025 revenue of $779 million, reflecting 5.9% year-over-year growth and 5.2% organic constant-currency expansion. Strength was driven by underwriting revenue growth of 8.7% and solid performance in claims, even amid relatively mild catastrophe activity.
Adjusted EBITDA rose 9.8% to $437 million, demonstrating operating leverage, while adjusted diluted EPS increased 13% to $1.82, exceeding consensus by $0.22. Full-year 2025 revenue reached $3.07 billion (+6.6%), with adjusted EPS of $7.16.
For FY2026, management projects:
-
Revenue of $3.19–$3.24 billion
-
Adjusted EBITDA of $1.79–$1.83 billion, implying margins around 56%
-
Adjusted EPS of $7.45–$7.75
Verisk also raised its dividend by 11% to $0.50 per share and expanded its share repurchase authorization to $2.5 billion, supported by strong free cash flow that rose 38% year over year in Q4.
Booz Allen Hamilton: Earnings Resilience Amid Revenue Pressure
Booz Allen Hamilton posted Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, reflecting the impact of a prolonged government shutdown and delayed contract funding. Excluding billable expenses, revenue declined 6.7%.
Despite softer sales, adjusted EBITDA held steady at $285 million, representing a 10.9% margin, as management emphasized cost controls. Adjusted diluted EPS rose 14.2% to $1.77, beating estimates by a wide margin, aided in part by tax-related benefits.
Backlog reached a record $38 billion, up 2% year over year, with a 1.1x last-twelve-month book-to-bill ratio. Updated FY2026 guidance calls for:
-
Revenue of $11.3–$11.4 billion
-
Adjusted EBITDA of $1.195–$1.215 billion
-
Adjusted EPS of $5.95–$6.15
-
Free cash flow of $825–$900 million
Management continues to prioritize growth in AI, cybersecurity, and defense-related programs as civil agency funding recovers.
Head-to-Head: Stability vs. Value
VRSK stands out for earnings quality, recurring subscription revenue, and industry-leading margins near 56%. Its growth profile is steady rather than explosive, but cash generation and shareholder returns remain compelling.
BAH, meanwhile, demonstrates earnings resilience despite near-term revenue declines. Its $38 billion backlog and scale offer long-term visibility, though dependence on federal budgets introduces volatility.
In short:
-
VRSK offers predictability, margin strength, and AI-enhanced analytics at a premium valuation.
-
BAH provides scale, backlog depth, and value pricing, with upside tied to normalization in government spending.
Tickeron AI Verdict
Tickeron AI currently favors VRSK with a 65% probability of outperformance over the next 12 months. The preference reflects VRSK’s stable growth, superior margins, and strong free cash flow conversion. While BAH’s low valuation and record backlog offer potential upside, ongoing revenue uncertainty tempers near-term enthusiasm.
BAH in upward trend: price expected to rise as it breaks its lower Bollinger Band on February 12, 2026
BAH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 35 cases where BAH's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on March 06, 2026. You may want to consider a long position or call options on BAH as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BAH just turned positive on March 02, 2026. Looking at past instances where BAH's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BAH advanced for three days, in of 325 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
BAH moved below its 50-day moving average on February 11, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BAH crossed bearishly below the 50-day moving average on February 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for BAH entered a downward trend on March 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.634) is normal, around the industry mean (16.196). P/E Ratio (12.150) is within average values for comparable stocks, (44.829). BAH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.004). Dividend Yield (0.027) settles around the average of (0.028) among similar stocks. P/S Ratio (0.888) is also within normal values, averaging (51.369).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BAH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BAH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a holding company which offers management & technology consulting services
Industry DataProcessingServices
Advertisement